Daily Briefing · Issue №120 · 2026-09-13

ARPA-H launches $63M effort to build FDA-authorized AI agents for heart failure care

• A key aspect of the initiative is close collaboration with the FDA to establish a regulatory framework for a new class of autonomous clinical AI.